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Abstract
Microbeam radiation therapy (MRT) using high doses of synchrotron X-rays can destroy tumours in animal models whilst
causing little damage to normal tissues. Determining the spatial distribution of radiation doses delivered during MRT at a
microscopic scale is a major challenge. Film and semiconductor dosimetry as well as Monte Carlo methods struggle to
provide accurate estimates of dose profiles and peak-to-valley dose ratios at the position of the targeted and traversed
tissues whose biological responses determine treatment outcome. The purpose of this study was to utilise c-H2AX
immunostaining as a biodosimetric tool that enables in situ biological dose mapping within an irradiated tissue to provide
direct biological evidence for the scale of the radiation burden to ‘spared’ tissue regions between MRT tracks. C-H2AX
analysis allowed microbeams to be traced and DNA damage foci to be quantified in valleys between beams following MRT
treatment of fibroblast cultures and murine skin where foci yields per unit dose were approximately five-fold lower than in
fibroblast cultures. Foci levels in cells located in valleys were compared with calibration curves using known broadbeam
synchrotron X-ray doses to generate spatial dose profiles and calculate peak-to-valley dose ratios of 30–40 for cell cultures
and approximately 60 for murine skin, consistent with the range obtained with conventional dosimetry methods. This
biological dose mapping approach could find several applications both in optimising MRT or other radiotherapeutic
treatments and in estimating localised doses following accidental radiation exposure using skin punch biopsies.
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Introduction
Microbeam radiotherapy (MRT) uses an array of microplanar
radiation beams, produced by collimating synchrotron X-rays, to
irradiate the biological target with beams of typically dozens of
micrometres width which are separated by a few hundred micrometres
(reviewed in [1,2]). Rather than fractionating the total treatment dose
in time to allow normal tissues to recover, as in conventional
radiotherapy, MRT utilises spatial fractionation to spare normal tissues
whichare surprisingly resistant to single acute doses of hundreds ofgray
(e.g. [3,4]).Conversely, tumours, despite being only partiallyexposed to
a high radiation dose, appear to be sensitive to MRT treatment in both
unidirectional and interlaced regimes, and can be controlled under
conditions where normal tissues are less damaged than with
conventional broad beam radiotherapy (e.g. [5,6]). Possible explana-
tions for these intriguing characteristics include differential microvas-
cular repair in normal tissues vs. tumours [7–9] and the bystander
effect/cellular communication [6,10]. As yet, however, no conclusive
data have emerged to fully support or refute these proposed effects.
One important parameter in MRT is the peak-to-valley dose
ratio (PVDR). It indicates how much radiation is given to the
‘spared’ tissue in a dose valley between two microbeams relative to
the peak dose in the centre of the beam. This parameter is
extremely important to help understand the clinical response to
different MRT conditions and is a prerequisite for systematically
optimising treatment regimens; yet its experimental measurement
with radiation dosimeters or its mathematical calculation using
Monte Carlo codes for radiation transport processes is very
complex and associated with large uncertainties (e.g. [11–15]).
Immunocytochemical detection of the phosphorylation of the
histone H2AX to form c-H2AX has been used extensively to
visualise and quantify ionising radiation-induced DNA double-
strand breaks (reviewed in [16,17]). Unlike any other current
method of measuring DNA damage, c-H2AX combines a number
of useful features: excellent sensitivity, in situ detection, simple
quantification, large dynamic range, single cell analysis and the
possibility to combine this marker with other immunocytochem-
ical or histological techniques. These features have led to its use as
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treated cell cultures or tissues [6,18,19]. Here we have used c-
H2AX immunostaining not only to visualise MRT tracks but to
quantify radiation-induced DNA damage between those tracks in
cultured fibroblasts and murine skin sections. Foci counts in these
valleys were compared with a calibration curve for c-H2AX foci
induction using known broad beam synchrotron X-rays doses to
estimate doses delivered as a function of distance from the nearest
MRT track and determine PVDR values in situ.
Materials and Methods
Ethics statement
All animal work was approved by the animal welfare
committees of the Japanese Synchrotron Radiation Research
Institute (SPring-8 approval ID 2007A1750) and Monash
University (approval ID MMCA 2007/29). Animals were
anaesthetized for all procedures.
Fibroblast cultures
Human MRC-5 foetal lung fibroblasts (obtained from ATCC,
#CCL-171) were cultured in EMEM with 2 mM glutamine, 1%
non essential amino acids and 10% foetal bovine serum (FBS) at
37uC in a humidified incubator at 5% CO2. Cells were grown to
confluence and irradiated in Nunc Flasks on Slides and returned to
the incubator immediately after irradiation.
Mouse preparation
Adult, female BALB/c mice were fed a standard rodent diet and
given water ad libitium in the animal house of the biomedical
imaging centre on the SPring-8 synchrotron campus. The animals
were anaesthetized using a 1:10 dilution of pentobarbitone
(Nembutal, Sigma Aldrich, St Louis, MO, USA) at a concentra-
tion of approximately 1 ml/kg (equivalent to 50 mg/kg body
weight). The hair along the animals’ back was shaved using a
standard electric rodent shaver. A skin flap was raised along the
animals’ back and pre-cut lengths of radiochromic film (Gafchro-
mic HD-810, ISP Corp, New Jersey, USA) were placed on both
sides of the skin flap to identify the entrance and exit radiation
fields. The mice were secured on a perspex jig by placing them
inside a 50 ml vial with a cut-away made to allow the skin flap to
be raised for irradiation [6].
Microbeam and broadbeam irradiations
All irradiations were carried out on beamline BL28B2 at the
SPring-8 synchrotron, Hyogo, Japan, using a similar setup as
described previously [6,11]. A bending magnet produced poly-
chromatic X-rays from electrons travelling at relativistic speeds
around a storage ring with energies of 8 GeV and a stable beam
current of approximately 100 mA. A fixed geometry, tungsten/
kapton collimator [12] was used to segment the incident, broad
beam into an array of quasi-parallel horizontal, planar micro-
beams. The thickness of the collimator in the direction of the beam
was approximately 5 mm. The nominal microbeam width was
25 mm, with a center-to-center spacing of 200 mm. The vertical
height of the incident, broad beam was 1 mm, producing five
micro-planar beams post-collimation. The exposure time was
adjusted by varying the opening time of an upstream lead shutter,
which blocked the X-ray beam. For the MRT treatments, copper
filters of 11.5 mm thickness were used to reduce the in-air
entrance dose rate from approximately 80 Gy/s to approximately
4 Gy/s, to enable the precise delivery of low doses within the
mechanical capabilities of the shutter. The mean energy of the
microbeam X-rays was 162 keV. For the broad beam calibration
studies, a total of 15.75 mm Cu, 7 mm Al, and 1 mm Fe were
used to reduce the dose rate to about 1.5 Gy/s. The mean X-ray
energy for the broadbeam studies was 175 keV.
One group of mice (n=3) were irradiated with uni-directional
MRT with the beam geometry described above, using different in-
beam entrance doses (3.9, 7.8, 13.7, 19.6, 48.8, and 97.5 Gy) in six
adjacent fields on the raised skin flap. A further group of mice
(n=3) were irradiated with a range of broad beam radiation
entrance doses (0.15, 0.45, 1.35, 1.8, 2.7, 3.6, and 4.5 Gy). Three
mice were used as sham-irradiated controls. These un-irradiated
mice were prepared, anaesthetized and positioned on the
treatment jig in an identical fashion to the irradiated mice.
Immediately post-irradiation, a fine-gauge needle containing
Evan’s Blue dye (Sigma Aldrich, St Louis, MO, USA) was used
to mark the corners of the irradiated fields on the mice skin using
the exposed radiochromic film as a visual guide. The mice
recovered from the anaesthesia and were returned to the animal
facility in the biomedical imaging centre at SPring-8. Using the
same beam geometry as above, fibroblast cultures in flask slides
were irradiated in duplicates with uni-directional MRT and broad
beam X-rays using different in-beam entrance doses (8, 10, 20, 50
and 100 Gy for MRT and 0.45, 0.9, 1.8, 2.7, 3.6 and 4.5 Gy for
broad beam). Again, sham-exposed controls underwent the same
treatment as exposed flask slides.
Fibroblast fixation, immunofluorescence staining and c-
H2AX foci scoring
Following MRT treatment and repair incubation of 30 min or
2 h, fibroblast cultures in Nunc Flasks on Slides were fixed with
3.7% formaldehyde in phosphate-buffered saline (PBS) for 15 min,
filled up with PBS and posted from Japan to the UK for
immunostaining and analysis. Permeabilisation with Triton X-
100, blocking and immunofluorescence staining with c-H2AX
antibody clone JBW301 (Upstate, Charlottesville, VA, USA) and
AlexaFluor488-conjugated anti-mouse secondary antibody (Invi-
trogen) were performed as previously described [20]. An
automated microscopy system with a 1006 lens (1.3NA) and
Hamamatsu ORCA-ER camera was used for acquiring z-stacks of
8 sequential focus planes in 0.5 mm steps per field of view and
TRI2 software (version 2.2) was used for foci scoring in maximum
intensity projection images and for spatial mapping of cells relative
to MRT tracks [21].
Tissue harvesting, processing and immunohistochemistry
for c-H2AX
Mice were culled by cervical dislocation at 30 min post-
irradiation. The skin flap was excised from the mouse, flattened
and fixed in formalin for at least six hours. Small sections of
irradiated tissue were removed with the cut surface oriented
perpendicular to the path of the microbeams. These were placed
into histology cassettes and returned to Australia in phosphate-
buffered saline for subsequent dehydration and embedding into
paraffin. Blocks of paraffin-embedded skin were then sent to the
UK for sectioning, immunohistochemical staining and analysis.
Four-micrometre sections of formalin-fixed paraffin-embedded
skin were deparaffinized, rehydrated and microwaved at 850 W
for 4 min in 10 mM citric acid for antigen retrieval. Slides were
stained in a DAKO autostainer using ChemMate EnVision
Detection Kit Peroxidase/DAB, Rabbit/Mouse (K5007, DAKO
UK Ltd., Ely, UK) and anti-c-H2AX antibody at 2.5 mg/ml
(clone JBW301, Upstate, Charlottesville, VA, USA). Slides were
weakly counterstained with haematoxylin. c-H2AX foci per
nucleus were scored by eye using bright field microscopy at
Biological Dose Mapping in Microbeam Radiotherapy
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to the closest microbeam track was measured using Motic Images
2.0 software on digital images obtained with a 206objective and
Moticam 2500 camera (Motic, Wetzlar, Germany).
Results
Human MRC-5 foetal lung fibroblast cultures in slide flasks
were fixed and immunostained for c-H2AX after 0.5 and 2 hour
incubations following exposure to different doses of micro-planar
beams of synchrotron X-rays. ‘Stripes’ of bright c-H2AX
immunofluorescence staining were observed which mirrored the
spatial distribution of the microbeams, as determined using
radiochromic films on the same samples (Figure 1A). The intensity
and width of the c-H2AX stripes increased with dose. In contrast
to a well defined stripe pattern seen with the 0.5 hour samples,
fibroblasts incubated for 2 hours showed a less defined geometrical
pattern, likely caused by increased cell movement during the
longer post-irradiation incubation period. All subsequent biodosi-
metric analyses of fibroblast cultures were performed using the
0.5 hour samples, to minimise artefacts associated with cell
migration. At higher magnification, foci were visible in cells
located in the ‘valleys’ between microbeam tracks (Figure 1B).
Their abundance increased with peak dose, and at the highest
peak dose of 100 Gy only cells in the centre of the valleys, i.e. as far
away from the tracks as possible, showed discernible foci whilst
cells closer to the tracks showed almost pan-nuclear c-H2AX
staining, as did the cells inside the tracks.
In order to calculate valley doses using c-H2AX foci as a
biodosimeter, a calibration curve was established using the same
irradiation conditions. To this end, fibroblast cultures in slide flasks
were exposed to different doses of broadbeams of the same
synchrotron X-rays that were used for microbeam irradiations.
Following incubation at 37uC for 0.5 hours, samples were fixed
and immunostained for c-H2AX. Z-stacks of fluorescence images
were acquired and analysed using the ‘object count’ module of the
Tri2 software [21]. Foci levels increased linearly with dose for
doses up to 1.8 Gy (Figure 1C), and a linear regression fit
produced a yield of 22.160.4 foci per cell per gray with a
background level of 0.9 (R
2=0.99). At higher doses, foci levels
saturated, probably due to increasing signal overlap (data not
shown); these samples were therefore excluded from the analysis.
The same image acquisition and analysis process was performed
with MRT-treated fibroblasts. Foci levels per cell were analysed as
a function of the distance of the centre of each cell nucleus from
the nearest MRT track, using the spatial information provided by
the Tri2 software. Considerable cell-to-cell variation but overall
declining foci levels with increasing distance were observed for all
doses; see Figure 1D for an example showing data for 20 Gy MRT
peak dose. To obtain average damage levels for conversion into
dose, cells in valley regions between microbeam tracks were
grouped into four distance categories (20–40, 40–60, 60–80 and
80–100 mm from the centre of the nearest microbeam track).
Figure 1E shows a very consistent relationship between relative
spatial position and foci levels for all the analysed MRT peak doses
ranging from 8 Gy to 50 Gy. These foci levels could be converted
to doses using the calibration curve in Figure 1C and are shown as
percentage of the peak dose for each irradiation condition in
Figure 1F. This indicates a dose-independent maximum peak-to-
valley ratio of 30–40 for the central valley region between two
microbeam planes. Foci levels at 100 Gy peak dose were too high
for reliable scoring.
To quantify dose distributions in irradiated tissues, skin sections
from mice held for 0.5 hours following exposure to different doses
of microplanar beams of synchrotron X-rays were immunostained
for c-H2AX and counterstained with hematoxylin. Stripe patterns
of brown c-H2AX staining were observed (Figure 2A; incident
beams from ,11 o’clock) which did not quite match the perfectly
parallel and regular patterns observed in fibroblast cultures in
Figure 1. Distortion and shrinkage of skin during tissue processing
and the inhomogenous distribution of cells, especially in the
dermis, may have contributed to this effect. Due to these
geometric distortions and the low overall cell density in skin
layers below the epidermis, scoring of c-H2AX foci as a function
of distance to the closest microbeam track was only feasible for
epidermal cells. As for fibroblasts, the intensity and width of the c-
H2AX stripes increased with dose (not shown).
At higher magnification, foci were visible in cells located in the
valleys between microbeam tracks whereas cells close to or within
the tracks showed almost pan-nuclear c-H2AX staining
(Figure 2B), as seen in Figure 1 for fibroblasts.
Again a calibration curve for foci yield versus radiation dose was
established. Using the same irradiation conditions as for MRT
treatments, skin flaps were exposed to different doses of broad-
beam synchrotron X-rays, excised 0.5 hours later and processed
using the same protocol as for the microbeam-treated mice. As
automated scoring of solid-stained c-H2AX foci in skin sections
using image analysis software was not available, foci were scored
manually at 10006magnification. Whilst there was again a linear
induction of c-H2AX foci with dose, their yield per unit dose was
significantly lower (Figure 2C). A linear regression fit produced a
yield of 4.2960.13 foci per cell per gray with a background level of
0.05 (R
2=0.99).
For MRT-treated skin, c-H2AX foci were scored in the same
way by eye and the distance of each cell nucleus to the nearest
MRT track was measured using the Motic Images 2.0 software.
Average foci levels and corresponding dose estimates for cells
grouped into distance categories relative to the nearest MRT track
are shown in Figure 2D for three different MRT peak doses. The
foci yields and dose estimates as a function of the distance from the
nearest microbeam have a similar profile to the data obtained for
fibroblasts (Figure 1E), and absolute dose estimates are very
similar, despite the considerable difference in absolute foci yields
per unit dose determined for the two different sample types and
methodological approaches used. Again the percentage of the peak
dose delivered to valley regions between tracks had a similar
minimum level furthest away from the MRT tracks (Figure 2E),
resulting in a maximum peak-to-valley dose ratio of approximately
60, somewhat higher than what had been observed for cell cultures
on slides (Figure 1F).
Discussion
The c-H2AX foci yield of 22.1 per cell per gray at 0.5 hours
after irradiation observed in fibroblasts in this study is similar to
yields of 20–25 per cell per gray at 0.25 hours after irradiation
reported in previous studies where fibroblasts were X-irradiated on
slides [20,22]. In contrast, the foci yield of only 4.3 per cell per
gray measured in skin sections is considerably lower. A number of
factors have probably contributed to this effect. Antigen masking
due to extended incubation in formalin was addressed by boiling
skin sections in citric acid but may still have resulted in reduced
antibody binding. Sectioning at 4 mm thickness conceivably cut off
parts of nuclei which are normally bigger in diameter, thus
reducing the average amount of DNA available for c-H2AX
staining. Solid-stained c-H2AX foci are not as crisp and easy to
score as immunofluorescence-stained foci, partly because of
masking effects of the hematoxylin counterstain which was
Biological Dose Mapping in Microbeam Radiotherapy
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29853nonetheless necessary – but used at a low staining intensity – to
enable reliable detection of cell nuclei. Together, these factors may
explain the five-fold discrepancy between foci yields in fibroblast
cultures and skin sections obtained in this study. Nonetheless, this
study confirms previous work indicating that chromogenic
immunohistochemical staining can be used to quantify ionising
radiation-induced foci in tissue sections [23,24].
The extensive movement of fibroblasts in culture observed as
early as 2 hours after MRT treatment is consistent with the
recently reported considerable tumour – but not skin – cell
movement in vivo [6]. To minimise distortion of the original
radiation geometry and associated flattening of the PVDR by cell
movement, cell cultures were incubated for only 30 min post-
irradiation, to allow c-H2AX foci to form, yet minimise cell
movement. However, even in these samples it is possible that
PVDRs have decreased slightly as a consequence of limited cell
movement. This may in fact be one reason for the slightly lower
PVDR values obtained for fibroblast cultures (30–40) compared to
skin sections (approximately 60) for the same MRT beam
geometry.
Nonetheless, it is reassuring that spatial distributions of foci
measured across valleys between microplanar beams were very
consistent and that PVDRs were still fairly compatible for these
two entirely distinct experimental setups, despite vastly different
absolute foci yields obtained by automated scoring in immunoflu-
orescence-stained fibroblast cultures and by manual scoring in
solid-stained murine skin sections (compare Figures 1C and 2C).
These PVDRs are similar to ratios measured for the same
collimator with radiochromic film [11] but considerably lower
than measurements using phosphor coupled to a charge-coupled
Figure 1. c-H2AX immunofluorescence analysis of human fibroblast cultures following microbeam radiotherapy. (A) ‘Stripes’ of c-
H2AX-stained cells are visible 30 min (top) and 2 h (bottom) after treatment with peak doses of 100 (left) and 50 Gy (right). (B) High magnification
images of cells in peak and valley regions 30 minutes after treatment with different peak doses. Scale bars in (A) and (B) are 200 mm. (C) Dose
response curve for foci induction 30 minutes after broadbeam synchrotron X-irradiation. The line shows a linear regression fit (y=22.1x+0.9;
R
2.0.99). (D) Foci levels in valley regions as a function of distance of the centre of the cell nucleus from the centre of the nearest microbeam track
with a peak dose of 20 Gy. Each data point represents one cell. The curve was fitted to guide the eye. (E) Calculation of radiation doses delivered to
valleys between microbeam peak doses of 8, 10, 20 and 50 Gy, based on the comparison of c-H2AX foci levels in valleys with the calibration curve in
panel C obtained for broadbeam-irradiated cultures. (F) Percentage of the peak dose as a function of distance from the centre of the nearest
microbeam track. Error bars are the standard deviation from the analysis of two separately irradiated cultures. Error bars for dose estimates ignore
uncertainties associated with the calibration curve.
doi:10.1371/journal.pone.0029853.g001
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transport [12]. It is important to note that PVDR values can
differ dramatically for different collimator geometries and
materials and also depend on the characteristics of the incident
X-ray beam, thickness of the tissue layers traversed by the
radiation, and depth of the targeted tissue layer. For the murine
skin experiments the thickness of the films and the skin have to be
considered, whereas for the fibroblast cultures the thickness of film
and slide flask material are important This makes it difficult to
compare different experimental setups, introduces considerable
complexity and uncertainty about the ‘true’ value and underlines
the importance of measuring dose profiles where they matter, i.e.
in the targeted and surrounding tissues whose biological responses
to MRT determine treatment outcome. This is exactly where c-
H2AX-based biodosimetry has its unique advantage over other
dosimetric methods, because it provides direct biological evidence
for the scale of the radiation burden to ‘spared’ tissue regions
located between planar microbeams.
Assuming that cell movement is independent of dose, it alone
cannot explain the relatively high foci levels observed for
fibroblasts located close to the track at low doses. The finding of
a similar effect at low doses in mouse skin where, in contrast to
implanted tumours and to the fibroblast cultures studied here, no
significant cell movement was observed for days following
microbeam irradiation [6], also suggests that cell movement alone
cannot explain this effect. Inter-cellular signalling between
neighbouring cells following irradiation, causing excess chromo-
somal aberrations and DNA damage foci in bystander cells, could
potentially explain this phenomenon and has indeed been
observed in cell cultures [25–27], three-dimensional tissue models
[28,29] and in vivo (reviewed in [30]). However, methodological
limitations could also have contributed. For example, human
scorers as well as image analysis software-based scoring procedures
tend to under-score in cells with high foci levels such as those very
close to a high dose microbeam. This systematic bias would have
exactly the effect observed here, although the absence of such a
bias in the broad beam calibration curve, i.e. no saturation of foci
yields towards high doses, argues against this notion. Additional
effort will be required to identify the mechanism underlying the
observed ‘anomaly’.
The relatively consistent dose estimates obtained for MRT-
treated cell cultures and skin suggest that c-H2AX foci analysis
represents a fairly robust and reproducible methodology for
spatially resolved in situ biodosimetry in biological tissues exposed
to complex radiation geometries. Such biological dose maps may
prove useful not only in further characterising clinically relevant
parameters in microbeam radiotherapy, where e.g. decreasing
PVDRs with penetration depth into the tissue could be
experimentally tested, but this technique, applied to a skin punch
biopsy, could potentially also be used in situations of accidental
radiation exposures with highly non-uniform dose distributions
where localised dose estimates could help inform clinical
management of the patient.
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